Cited by 165Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthLipid metabolism and disorders

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans

Persson, Lena, Cao, Guoqing, Ståhle, Lars, Sjöberg, Beatrice G., Troutt, Jason S., Konrad, Robert J., Gälman, Cecilia, Wallén, Håkan +7 more·2010·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— To gain insight into the function of proprotein convertase subtilisin kexin type 9 (PCSK9) in humans by establishing whether circulating levels are influenced by diurnal, dietary, and hormonal changes. Methods and Results— We monitored circulating PCSK9 in a set of dynamic human experiments and could show that serum PCSK9 levels display a diurnal rhythm that closely parallels that of cholesterol synthesis, measured as serum lathosterol. In contrast to these marked diurnal changes in cholesterol metabolism, serum low-density lipoprotein (LDL) cholesterol levels remained stable during the diurnal cycle. Depletion of liver cholesterol by treatment with the bile acid–binding resin, cholestyramine, abolished the diurnal rhythms of both PCSK9 and lathosterol. Fasting (>18 hours) strongly reduced circulating PCSK9 and lathosterol levels, whereas serum LDL levels remained unchanged. Growth hormone, known to be increased during fasting in humans, reduced circulating PCSK9 in parallel to LDL cholesterol levels. Conclusion— Throughout the day, and in response to fasting and cholesterol depletion, circulating PCSK9 displays marked variation, presumably related to oscillations in hepatic cholesterol that modify its activity in parallel with cholesterol synthesis. In addition to this sterol-mediated regulation, additional effects on LDL receptors may be mediated by hormones directly influencing PCSK9.

Integrity signals

Registry

Crossref · 10.1161/atvbaha.110.214130

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PCSK9 expression is also observed in adult mouse and human cerebellum and can be measured in human cerebrospinal fluid.

    “however, PCSK9 expression is also observed in adult mouse and human cerebellum (Seidah et al., 2003; gtexportal.org) and can be measured in human cerebrospinal fluid (CSF) (Persson et al., 2010; Chen et al., 2014).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Persson, L., Cao, G., Ståhle, L., Sjöberg, B. G., Troutt, J. S., Konrad, R. J., Gälman, C., Wallén, H., Eriksson, M., Hafström, I., Lind, S., Dahlin, M., Åmark, P., Angelin, B., & Rudling, M.
Affiliations
  • Karolinska University Hospital (SE)
  • From the Department of Endocrinology, Metabolism and Diabetes and the Center for Biosciences and Nutrition, Department of Medicine (L.P., B.G.S., C.G., M.E., B.A., and M.R.), Karolinska Institutet at Karolinska University Hospital at Huddinge, Stockholm, Sweden; Lilly Research Laboratories (G.C., J.S.T., and R.J.K.), Division of Eli Lilly and Company, Indianapolis, Ind. USA; the Division of Clinical Pharmacology (L.S.), Karolinska Institutet at Karolinska University Hospital at Huddinge, Stockholm,...
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2010-12
Volume
30
Issue
12
Pages
2666-2672
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2146010644
Cited by
165
References
1
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 14 · 2021: 9 · 2020: 12 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 13 · 2013: 15 · 2012: 7
FWCI
10.61
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
PCSK9, diurnal cycle, cholesterol biosynthesis, lathosterol, fasting, LDL cholesterol, cholestyramine, bile acid sequestrants, growth hormone, liver cholesterol, LDL receptor, circadian rhythm, serum PCSK9 levels
MeSH terms
Atorvastatin, Proprotein Convertase 9, Anticholesteremic Agents, Energy Intake, Cholesterol, Cholestyramine Resin, Circadian Rhythm, Fasting, Female, Heptanoic Acids, Humans, Cholesterol, LDL, Liver, Male, Pyrroles, Receptors, LDL, Serine Endopeptidases, Sweden, Down-Regulation, Cross-Over Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Human Growth Hormone, Proprotein Convertases, Diet, Ketogenic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review